Amarin Corporation Overview

  • Year Founded
  • 1989

Year Founded

  • Status
  • Public

  • Employees
  • 80

Employees

  • Stock Symbol
  • AMRN

Stock Symbol

  • Investments
  • 4

  • Share Price
  • $10.55
  • (As of Friday Closing)

Amarin Corporation General Information

Description

Amarin Corp PLC is a pharmaceutical company. The company is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa. The company focuses on treatments to stop cardiovascular disease causing death, by providing patients, doctors and investors with reliable cardiovascular treatment options. Geographically, the company derives maximum revenue from United States.

Contact Information

Formerly Known As
Ethical Holdings, Amarin Pharmaceuticals
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • One Central Plaza
  • Dame Street, Dublin 2
  • Dublin D02 K7K5
  • Leinster
  • Ireland
+353 (01)
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Stock Exchange
NAS
Corporate Office
  • One Central Plaza
  • Dame Street, Dublin 2
  • Dublin D02 K7K5
  • Leinster
  • Ireland
+353 (01)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Amarin Corporation Stock Performance

As of 20-Nov-2026, Amarin Corporation’s stock price is $10.55. Its current market cap is $222M with 42M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$10.55 $11.25 $10.55 - $17.31 $222M 42M 78.9K -$0.80

Amarin Corporation Financials Summary

As of 30-Sep-2026, Amarin Corporation has a trailing 12-month revenue of $176M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV (36,796) 10,306 (98,018) 43,522
Revenue 176,112 213,646 228,614 306,911
EBITDA (24,926) (43,866) (87,583) (62,560)
Net Income (19,141) (38,798) (82,183) (59,112)
Total Assets 634,081 670,775 685,349 831,684
Total Debt 5,353 6,080 7,723 8,737
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Amarin Corporation Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Amarin Corporation‘s full profile, request access.

Request a free trial

Amarin Corporation Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Amarin Corp PLC is a pharmaceutical company. The company is focused on the commercialization and development of therapeu
Drug Discovery
Dublin, Ireland
80 As of 2025

Toluca, Mexico
 

Northvale, NJ
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Amarin Corporation Competitors (23)

One of Amarin Corporation’s 23 competitors is Landsteiner Scientific, a Formerly PE-Backed company based in Toluca, Mexico.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Landsteiner Scientific Formerly PE-Backed Toluca, Mexico
Elite Pharmaceuticals Corporation Northvale, NJ
Mayne Pharma Group Corporation Salisbury, Australia
Acura Pharmaceuticals Formerly VC-backed Palatine, IL
Cipla Corporation Mumbai, India
You’re viewing 5 of 23 competitors. Get the full list »

Amarin Corporation Patents

Amarin Corporation Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2024102429-A1 Methods of reducing risks of cardiovascular events in subjects with low baseline epa:aa ratio Inactive 10-Nov-2022
AU-2023213684-A1 Lymph-releasing compositions of fatty acids and uses thereof for lymphatic incorporation and systemic disease treatment Pending 26-Jan-2022
EP-4468884-A1 Lymph-releasing compositions of fatty acids and uses thereof for lymphatic incorporation and systemic disease treatment Pending 26-Jan-2022
EP-4468884-A4 Lymph-releasing compositions of fatty acids and uses thereof for lymphatic incorporation and systemic disease treatment Pending 26-Jan-2022
US-20240165066-A1 Lymph-releasing compositions of fatty acids and uses thereof for lymphatic incorporation and systemic disease treatment Pending 26-Jan-2022 A23J7/00
To view Amarin Corporation’s complete patent history, request access »

Amarin Corporation Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Amarin Corporation Investments & Acquisitions (4)

Amarin Corporation’s most recent deal was a Merger/Acquisition with Ester Neurosciences for . The deal was made on 01-Dec-2007.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Ester Neurosciences 01-Dec-2007 Merger/Acquisition Other Devices and Supplies
Laxdale 08-Oct-2004 Merger/Acquisition Buildings and Property
VASCEPA 01-Jan-2004 Merger/Acquisition Pharmaceuticals
Antares Pharma 01-Dec-1993 Early Stage VC Drug Delivery
To view Amarin Corporation’s complete investments and acquisitions history, request access »

Amarin Corporation ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Biotechnology

Subindustry

Rank

Percentile

To view Amarin Corporation’s complete esg history, request access »

Amarin Corporation Exits (1)

Amarin Corporation’s most recent exit was on 01-Dec-1993 from Antares Pharma. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Antares Pharma 01-Dec-1993 Completed
To view Amarin Corporation’s complete exits history, request access »

Amarin Corporation Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
VASCEPA Bedminster Township, NJ

Amarin Corporation FAQs

  • When was Amarin Corporation founded?

    Amarin Corporation was founded in 1989.

  • Where is Amarin Corporation headquartered?

    Amarin Corporation is headquartered in Dublin, Ireland.

  • What is the size of Amarin Corporation?

    Amarin Corporation has 80 total employees.

  • What industry is Amarin Corporation in?

    Amarin Corporation’s primary industry is Drug Discovery.

  • Is Amarin Corporation a private or public company?

    Amarin Corporation is a Public company.

  • What is Amarin Corporation’s stock symbol?

    The ticker symbol for Amarin Corporation is AMRN.

  • What is the current stock price of Amarin Corporation?

    As of 20-Nov-2026 the stock price of Amarin Corporation is $10.55.

  • What is the current market cap of Amarin Corporation?

    The current market capitalization of Amarin Corporation is $222M.

  • What is Amarin Corporation’s current revenue?

    The trailing twelve month revenue for Amarin Corporation is $176M.

  • Who are Amarin Corporation’s competitors?

    Landsteiner Scientific, Elite Pharmaceuticals, Mayne Pharma Group, Acura Pharmaceuticals, and Cipla are some of the 23 competitors of Amarin Corporation.

  • What is Amarin Corporation’s annual earnings per share (EPS)?

    Amarin Corporation’s EPS for 12 months was -$0.80.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process